Draft v1.0
Comprehensive guidelines for the ethical, safe, and effective implementation of psychedelic-assisted therapy in healthcare.
The Eden Framework provides comprehensive guidelines for the ethical, safe, and effective implementation of psychedelic-assisted therapy in healthcare. It is designed for healthcare providers, including facilitators, therapists, and medical doctors, and covers multiple psychedelic substances while addressing substance-specific considerations where necessary. The framework aims to influence policy, facilitate the integration of psychedelic therapy into healthcare systems, and ensure adherence to safety standards, ethical conduct, therapist training, and regulatory considerations.
Substances Covered: This framework applies to various psychedelic substances, including but not limited to psilocybin, MDMA, LSD, DMT, mescaline, and ketamine. While the general principles apply across substances, specific safety and therapeutic considerations are outlined for each where necessary.
Target Audience: The framework is designed for licensed healthcare providers, including psychotherapists, psychiatrists, general medical practitioners, and trained facilitators who support psychedelic therapy.
Clinical and Research Use: The framework provides standards applicable in both approved clinical therapy and research settings where psychedelics are legally utilized.
Regulatory Alignment: While the framework seeks to align with legal regimes where possible, its primary focus is the safe and effective application of psychedelic therapies.
Patients must be provided with a detailed explanation of the therapy, including potential risks, benefits, duration, effects, possible psychological responses, and contraindications. Consent must be obtained in writing and revisited throughout the therapeutic process.
Practitioners must comply with all applicable laws and ethical guidelines regarding patient confidentiality. Information about participants should not be disclosed without their explicit consent, except in situations where harm to self or others is a concern.
Clear professional boundaries must be maintained at all times. Sexual, financial, or personal exploitation of participants is strictly prohibited. Therapists must remain professional, ethical, and respectful of participants' vulnerabilities.
Providers must acknowledge and respect the diverse cultural, spiritual, and personal backgrounds of patients. Indigenous and traditional knowledge about psychedelic use should be recognized and honored where relevant.
Practitioners must communicate openly about their qualifications, experience, fees, and the experimental nature of certain treatments. Misrepresentation of psychedelic therapy as a guaranteed cure is unethical and prohibited.
Patients must undergo thorough pre-screening for mental health conditions, medications, medical history, and any contraindications such as psychotic disorders, cardiovascular issues, or other unstable conditions.
Therapy must take place in a controlled environment designed to foster safety and support. The setting should be comfortable, private, and free from disruptions. Therapists must ensure that patients are psychologically and emotionally prepared for their experiences.
Preparation Phase: Multiple sessions to establish trust, discuss expectations, and prepare the patient for the psychedelic experience.
Dosing Session: Supervised administration in a controlled environment with trained professionals present.
Integration Phase: Follow-up sessions to help patients process and apply insights gained from the experience.
Therapists must have protocols for handling adverse reactions, including anxiety, paranoia, or physical distress. Emergency contacts, medical support, and de-escalation techniques must be in place.
Certain substances require unique safety protocols (e.g., MDMA may necessitate hydration monitoring, while ayahuasca may require dietary restrictions).
Preferably, practitioners should be licensed mental health professionals (e.g., psychotherapists, psychiatrists, psychologists, social workers, or medical doctors). In jurisdictions where non-licensed facilitators are permitted, they must undergo rigorous training and certification.
Providers must complete accredited training programs covering:
Before independent practice, providers must undergo supervised sessions under the mentorship of an experienced practitioner.
Practitioners must engage in continuous education, periodic re-certification, and professional supervision to maintain competence.
Accreditation for Practitioners: A voluntary certification program will be available for providers who meet the training and practice requirements outlined in the framework.
Training Program Accreditation: Training organizations must meet Eden Framework standards to be recognized as approved providers of psychedelic therapy education.
Ethical Oversight: An independent body will oversee compliance, review complaints, and address violations of ethical guidelines.
Complaint Mechanism: A system will be established to allow patients and colleagues to report misconduct, with a structured process for investigation and remedial actions.
Phase 1: Research and Evidence Building
Continued clinical trials and data collection to refine therapy protocols and establish efficacy.
Phase 2: Regulatory Engagement and Approval
Advocacy for medical rescheduling and collaboration with regulatory bodies to define approved medical uses.
Phase 3: Training and Credentialing
Expansion of accredited training programs and certification processes to prepare practitioners for legal therapeutic use.
Phase 4: Pilot Clinics and Centers of Excellence
Establishment of licensed treatment centers to evaluate real-world application and refine best practices.
Phase 5: Insurance Recognition and Healthcare Integration
Engagement with insurers and policymakers to enable coverage and reimbursement for psychedelic-assisted therapy.
Phase 6: Scaling and Continuous Evaluation
Expanding access while maintaining high ethical and safety standards, ensuring quality control through continuous assessment and improvement.
The Eden Framework is a foundational guide for the responsible implementation of psychedelic-assisted therapy in healthcare. By adhering to these standards, practitioners can contribute to the ethical, safe, and effective integration of these therapies, providing transformative mental health solutions while maintaining professional and regulatory integrity. The framework will evolve as new research emerges, ensuring that psychedelic-assisted therapy remains at the forefront of evidence-based practice.
Want to contribute to the development of the Eden Framework?
Submit Feedback